Saturday 17 October 2026
Export CRKN’s income statement to Excel — free account
Crown Electrokinetics Corp.
CRKN Basic Materials Specialty Chemicals
Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023. In the quarter to March 2025, revenue grew 306.5%, EPS grew 99.8% and free cash flow fell 362.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.00
0.01
−100.00%
Follow CRKN
| Dec '24 | Dec '23 | Dec '22 | Mar '22 | Dec '21 | Mar '21 | Mar '20 | Dec '19 | Mar '19 | Dec '18 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.04 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
Altman Z-Score |
52.49 | 87.57 | — | — | — | — | — | — | — | — |
P/S ratio |
64.12 | 3,691.35 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(13.78) | (53.95) | — | — | — | — | (397.55) | — | (97.90) | (97.90) |
P/FCF ratio |
0.00 | 0.00 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
P/Operating CF |
(196.78) | (214.74) | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
P/B ratio |
56.79 | 199.68 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
Price to Tangible BV |
59.91 | 283.43 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
EV/Sales |
63.46 | 3,688.57 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
EV/Operating CF |
(68.76) | (57.76) | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
EV/FCF |
(51.39) | (50.91) | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
Quick Ratio |
1.72 | 0.30 | 0.17 | 0.17 | 9.23 | 16.37 | 0.01 | — | 0.03 | 0.03 |
Current Ratio |
2.13 | 0.50 | 0.30 | 0.30 | 10.27 | 16.74 | 0.01 | 0.00 | 0.05 | 0.05 |
Net Debt/EBITDA |
0.62 | 0.12 | 0.06 | (0.04) | 0.00 | 0.93 | 0.01 | 0.00 | 0.06 | 0.06 |
Debt/Assets |
1.94% | 0.00% | 0.00% | 20.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.03 | 0.00 | 0.00 | 2.58 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Asset Turnover |
0.89 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.00 | 0.75 | 0.86 |
Operating CF/Net income |
0.56 | 0.54 | 0.78 | 0.78 | — | 0.16 | 0.11 | (0.89) | 0.38 | 0.38 |
Capex/Depreciation |
(1.92) | (0.20) | (0.76) | 0.00 | — | (0.58) | (0.02) | (0.02) | (0.10) | (0.10) |
Interest Coverage |
(24.27) | (2.05) | (2,158.29) | — | — | (6.05) | (5.23) | — | (2.33) | (2.33) |
| (241.21%) | (1,139.24%) | (2,711.32%) | (301.95%) | 0.00% | (846.73%) | 185.49% | 0.00% | 126.55% | 220.51% | |
| (145.89%) | (368.06%) | (218.06%) | (176.95%) | 0.00% | (455.10%) | (3,018.67%) | (2,086.22%) | (638.31%) | (729.34%) | |
ROIC |
(163.47%) | (333.54%) | 0.00% | 0.00% | 0.00% | (937.46%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(155.75%) | (2,429.16%) | 766.81% | 44,906.25% | 0.00% | (273.21%) | 133.47% | (75,621.26%) | 113.82% | 113.82% |
Average Days of Receivables |
99.23 | 198.01 | — | — | — | — | 0.00 | — | 17.93 | 17.93 |
Research and Development Expense of Revenue |
17.09% | 1,833.33% | 0.00% | 0.00% | — | 0.00% | 1,826.10% | — | 141.07% | 141.05% |
Selling, General and Administrative Expense of Revenue |
101.75% | 9,851.63% | 0.00% | 0.00% | — | 0.00% | 5,491.80% | 0.00% | 354.81% | 354.81% |
Intangible Assets out of Total Assets |
0.03 | 0.15 | 0.24 | 0.24 | 0.18 | 0.09 | 0.60 | 0.95 | 0.41 | 0.41 |
Share Based Compensation of Revenue |
26.65% | 466.67% | 0.00% | — | — | 0.00% | 4,496.20% | — | 201.01% | 0.00% |
Graham Net Nets |
0.01 | 0.00 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
Graham Number |
0.00 | 5,990.76 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
Earnings Yield |
(2,953.22%) | 2,701.76% | — | — | — | — | 0.00% | — | 0.00% | 0.00% |
Free Cash Flow Yield |
(1.93%) | (1.96%) | — | — | — | — | 0.00% | — | 0.00% | 0.00% |
Revenue per Share |
0.33 | 0.56 | 0.00 | 0.00 | — | 0.00 | 0.02 | — | 0.05 | 0.00 |
Operating CF per Share |
(0.31) | (59.40) | 0.00 | (38.33) | — | (0.74) | (0.25) | 0.00 | (0.15) | 0.00 |
Capex per Share |
(0.10) | (7.99) | 0.00 | 0.00 | — | (0.18) | (0.01) | 0.00 | (0.01) | 0.00 |
Free Cash Flow per Share |
(0.41) | (67.39) | 0.00 | (38.33) | — | (0.93) | (0.26) | 0.00 | (0.16) | 0.00 |
Cash per Share |
0.23 | 3.89 | 0.00 | 2.83 | 0.00 | 1.73 | 0.01 | — | 0.01 | 0.00 |
Shareholders Equity per Share |
0.38 | 17.19 | 0.00 | 1.82 | 0.00 | 1.87 | (1.69) | — | (0.32) | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | — | 0.00 | — |
Book value per Share |
0.38 | 17.19 | 0.00 | 1.82 | 0.00 | 1.87 | (1.69) | — | (0.32) | 0.00 |
Free Cash Flow |
(24.33) | (18.33) | (11.95) | (11.14) | — | (8.22) | (1.07) | 8.53 | (1.72) | (1.72) |
Working Capital |
12.51 | (1.91) | (3.28) | (3.28) | 6.15 | 14.71 | (7.29) | 0.01 | (3.88) | (3.88) |
Capital Expenditures |
(6.14) | (2.17) | (0.81) | (0.81) | — | (1.63) | (0.03) | (0.03) | (0.11) | (0.11) |
Net Current Asset Value |
10.85 | (2.98) | (4.65) | (4.65) | 6.15 | 14.71 | (7.29) | 0.01 | (3.88) | (3.88) |
EV/EBIT |
0.00 | 0.00 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
Capex to Sales |
0.31 | 14.20 | 0.00 | — | — | 0.00 | 0.27 | 0.00 | 0.22 | 0.22 |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — | 0.00 | — | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.38 | 3.42 | 0.76 | 0.31 | 0.00 | 13.47 | 13.49 | 0.00 | 10.26 | 10.26 |
Cash ROIC |
(66.42%) | (319.58%) | (884.68%) | (410.01%) | 0.00% | (25.78%) | 15.49% | 0.00% | 52.34% | 52.33% |
Accounts Receivable Turnover |
7.24 | 2.84 | — | — | — | — | 0.00 | — | 20.35 | 0.00 |
Accounts Payable Turnover |
5.89 | 0.79 | 0.00 | 1.63 | 0.00 | 0.13 | 0.70 | — | 1.19 | 2.02 |
Inventory Turnover |
0.00 | 0.00 | — | 0.00 | — | 0.00 | 0.00 | — | 0.00 | 0.00 |
Average Days of Payables |
97.21 | 586.19 | 0.00 | 316.68 | 0.00 | 1,011.29 | 743.19 | — | 307.81 | 307.93 |
Days of Inventory on Hand |
0.00 | 0.00 | — | 0.00 | — | 0.00 | 0.00 | — | 0.00 | 0.00 |
Average Receivables |
2.72 | 0.05 | — | — | — | — | — | — | 0.02 | — |
Average Payables |
3.47 | 1.18 | 0.87 | 0.61 | 0.32 | 0.77 | 0.89 | — | 0.52 | 0.30 |
Average Assets |
22.26 | 8.06 | 6.59 | 8.12 | 13.59 | 8.96 | 0.32 | 0.46 | 0.67 | 0.59 |
Average Common Equity |
13.46 | 2.60 | 0.53 | 4.76 | 12.79 | 4.81 | (5.18) | — | (3.39) | (1.95) |
Columns are period end dates